Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Safinamide> ?p ?o. }
Showing items 1 to 60 of
60
with 100 items per page.
- Safinamide abstract "Safinamide (EMD 1195686) is a candidate drug against Parkinson's disease with multiple methods of action. In 2007, a Phase III clinical trial was started. It was scheduled to run until 2011. The compound was originally discovered at Farmitalia-Carlo Erba and developed by Newron Pharmaceuticals, which sold the rights to Merck-Serono in 2006. In October 2011 Merck-Serono announced that they would give all rights to develop the compound back to Newron.Potential additional uses might be restless legs syndrome (RLS) and epilepsy. They were being tested in Phase II trials in 2008, but no results are available.".
- Safinamide atcPrefix "none".
- Safinamide casNumber "133865-89-1".
- Safinamide casSupplemental "(mesylate)".
- Safinamide fdaUniiCode "90ENL74SIG".
- Safinamide iupacName "N2-{4-[(3-fluorobenzyl)oxy]benzyl}-(L)-alaninamide".
- Safinamide pubchem "131682".
- Safinamide thumbnail Safinamide.svg?width=300.
- Safinamide wikiPageID "18911525".
- Safinamide wikiPageRevisionID "576950539".
- Safinamide atcPrefix "none".
- Safinamide c "17".
- Safinamide casNumber "133865".
- Safinamide chembl "396778".
- Safinamide chemspiderid "116349".
- Safinamide f "1".
- Safinamide h "19".
- Safinamide hasPhotoCollection Safinamide.
- Safinamide inchi "1".
- Safinamide inchikey "NEMGRZFTLSKBAP-LBPRGKRZBO".
- Safinamide iupacName "N2-{4-[oxy]benzyl}-(L)-alaninamide".
- Safinamide kegg "D10158".
- Safinamide legalStatus "Investigational".
- Safinamide molecularWeight "302.34".
- Safinamide n "2".
- Safinamide o "2".
- Safinamide pubchem "131682".
- Safinamide smiles "O=C[C@@H]C".
- Safinamide stdinchi "1".
- Safinamide stdinchikey "NEMGRZFTLSKBAP-LBPRGKRZSA-N".
- Safinamide synonyms "-2".
- Safinamide unii "90".
- Safinamide verifiedfields "changed".
- Safinamide verifiedrevid "464386010".
- Safinamide subject Category:Monoamine_oxidase_inhibitors.
- Safinamide subject Category:Organofluorides.
- Safinamide type Agent114778436.
- Safinamide type Antidepressant102718811.
- Safinamide type CausalAgent100007347.
- Safinamide type Drug103247620.
- Safinamide type Matter100020827.
- Safinamide type Medicine103740161.
- Safinamide type MonoamineOxidaseInhibitor103783017.
- Safinamide type MonoamineOxidaseInhibitors.
- Safinamide type PhysicalEntity100001930.
- Safinamide type Substance100020090.
- Safinamide type Drug.
- Safinamide type DrugProduct.
- Safinamide type FunctionalSubstance.
- Safinamide comment "Safinamide (EMD 1195686) is a candidate drug against Parkinson's disease with multiple methods of action. In 2007, a Phase III clinical trial was started. It was scheduled to run until 2011. The compound was originally discovered at Farmitalia-Carlo Erba and developed by Newron Pharmaceuticals, which sold the rights to Merck-Serono in 2006.".
- Safinamide label "Safinamid".
- Safinamide label "Safinamide".
- Safinamide sameAs Safinamid.
- Safinamide sameAs m.04jmqqw.
- Safinamide sameAs Q2211523.
- Safinamide sameAs Q2211523.
- Safinamide sameAs Safinamide.
- Safinamide wasDerivedFrom Safinamide?oldid=576950539.
- Safinamide depiction Safinamide.svg.
- Safinamide isPrimaryTopicOf Safinamide.
